Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

Let us hope Odidi comes to his sense. He alone doesn't have the resources to move a drug through timely approval. I think he realized that with Rexista.

The minimal funding he's putting into Rexista trying to cut corners for FDA approval only to end in disaster with missing trials and missing data. That's telling us, he's cutting corners. I don't think he doesn't know about these requirement because FDA spokes person plainly said, IPCI did not submit the required data.

He needs a strong partner to help him advance the pipeline. The small raise here and there won't be anything near enough to push a product to the market in a timely fashion.

PODRAS is the meat and bone of IPCI. Any early trial success will generate interest in investing in IPCI.